FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rolf-Peter Mueller

Research Profile

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Fluorouracil

Anatomy

Organs at Risk

Co-author Network

Publications

TOP 3
Martin Kocher; Robert Semrau; Volker Sturm; Harald Treuer; Moritz Hoevels; Rolf-Peter Mueller
Endocrine and visual function after fractionated stereotactic radiotherapy of perioptic tumors.
Riccardo Soffietti; Gloria Tridello; Tzahala Tzuk-Shina; Egils Valeinis; Dirk van den Berge; Salvador Villa; Ufuk M Abacioglu; Brigitta Baumert; Mohamed Ben Hassel; Christian Carrie; Laurence Collette; Laura Fariselli; francois fauchon; Martin Kocher; Rolf-Dieter Kortmann; Mauri Kouri; Rolf-Peter Mueller; Andrew Bottomley
A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
J Kriz; G Kuhnert; H Mueller; Rolf-Peter Mueller; A Engert; Uwe Haverkamp; Carsten Kobe; Hans Theodor Eich
Large mediastinal tumor mass as a prognostic factor in Hodgkin's lymphoma. Is the definition on the basis of a chest radiograph in the era of CT obsolete?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rolf-Peter Mueller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Martin Kocher; Robert Semrau; Volker Sturm; Harald Treuer; Moritz Hoevels; Rolf-Peter Mueller
Endocrine and visual function after fractionated stereotactic radiotherapy of perioptic tumors.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2013;189(2):137-41.
2013: Riccardo Soffietti; Gloria Tridello; Tzahala Tzuk-Shina; Egils Valeinis; Dirk van den Berge; Salvador Villa; Ufuk M Abacioglu; Brigitta Baumert; Mohamed Ben Hassel; Christian Carrie; Laurence Collette; Laura Fariselli; francois fauchon; Martin Kocher; Rolf-Dieter Kortmann; Mauri Kouri; Rolf-Peter Mueller; Andrew Bottomley
A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(1):65-72.
2012: J Kriz; G Kuhnert; H Mueller; Rolf-Peter Mueller; A Engert; Uwe Haverkamp; Carsten Kobe; Hans Theodor Eich
Large mediastinal tumor mass as a prognostic factor in Hodgkin's lymphoma. Is the definition on the basis of a chest radiograph in the era of CT obsolete?
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2012;188(11):1020-4.
2012: J Koeck; J Kriz; Y Abo-Madyan; Hans Theodor Eich; J Fleckenstein; Rolf-Peter Mueller; F Stieler; Frederik Wenz; Frank Lohr
Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin's disease.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2012;188(8):653-9.
2012: J Kriz; Rolf-Peter Mueller; A Engert; Uwe Haverkamp; Christopher Bangard; C Baues; Rudolf Bongartz; Hans Theodor Eich
Quality control of involved-field radiotherapy for patients with early stage Hodgkin's lymphoma based on a central prospective review. Comparison of the results between two study generations of the German Hodgkin Study Group.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2012;188(8):660-5.
2012: Julia Koeck; Jan Kriz; Frank Lohr; Rolf-Peter Mueller; Florian Stieler; Frederik Wenz; Yasser Abo-Madyan; Hans Theodor Eich
Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
International journal of radiation oncology, biology, physics 2012;83(1):268-76.
2012: M J R Runge; Harald Treuer; Jürgen Voges; F El Majdoub; Stefan Hunsche; Martin Kocher; Mohammad Maarouf; Rolf-Peter Mueller; M I Ruge; Volker Sturm
LINAC-radiosurgery for nonsecreting pituitary adenomas. Long-term results.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2012;188(4):319-25.
2012: Bastian Von Tresckow; Josée M Zijlstra; Peter Borchmann; Volker Diehl; Hans Theodor Eich; Michael Fuchs; richard greil; Beate Klimm; Zdenek Kral; Andreas Lohri; Jana Markova; Julia Meissner; Rolf-Peter Mueller; Annette Plütschow; Martin Soekler; Harald Stein; Max S Topp; Andreas Engert
Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German hodgkin study group HD14 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(9):907-13.
2011: Peter Borchmann; Thomas Cerny; Volker Diehl; Bernd Dörken; Hans Theodor Eich; Michael Fuchs; richard greil; Heinz Haverkamp; Anthony D Ho; Christoph Huber; Lothar Kanz; Stefan W Krause; Jana Markova; Rolf-Peter Mueller; Hans-Konrad Mueller-Hermelink; Christoph Nerl; Ursula Paulus; Andreas Rank; Lenka Smardova; Andreas Engert
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(32):4234-42.
2011: Martin Kocher; Riccardo Soffietti; Ufuk Abacioglu; Salvador Villà; francois fauchon; Brigitta Baumert; Laura Fariselli; Tzahala Tzuk-Shina; Rolf-Dieter Kortmann; Christian Carrie; Mohamed Ben Hassel; Mauri Kouri; Egils Valeinis; Dirk van den Berge; Sandra Collette; Laurence Collette; Rolf-Peter Mueller
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(2):134-41.
2008: Carsten Kobe; Markus Dietlein; Jeremy Franklin; Jana Markova; Andreas Lohri; Holger Amthauer; Susanne Klutmann; WH Knapp; Josee M Zijlstra; Andreas Bockisch; Matthias Weckesser; Reinhard Lorenz; Mathias Schreckenberger; Roland Bares; Hans Theodor Eich; Rolf-Peter Mueller; Michael Fuchs; Peter Borchmann; Harald Schicha; Volker Diehl; Andreas Engert
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.
Blood 2008;112(10):3989-94.
2008: Jens Peter Klussmann; T Ponert; Rolf-Peter Mueller; Hans P Dienes; Orlando Guntinas-Lichius
Patterns of lymph node spread and its influence on outcome in resectable parotid cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2008;34(8):932-7.
2007: Simon Florian Preuss; Vera Dinh; Jens Peter Klussmann; Robert Semrau; Rolf-Peter Mueller; Orlando Guntinas-Lichius
Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience.
Oral oncology 2007;43(4):402-7.
2007: Orlando Guntinas-Lichius; M P Kreppel; Hartmut Stuetzer; Robert Semrau; Hans Edmund Eckel; Rolf-Peter Mueller
Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2007;33(2):222-8.
2007: Klaus L Prenzel; Alexandra König; Paul M Schneider; Christian Schnickmann; Stephan E Baldus; Wolfgang Schröder; Elfriede Bollschweiler; Hans P Dienes; Rolf-Peter Mueller; Jakob R Izbicki; Arnulf H Hölscher
Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
Annals of surgical oncology 2007;14(2):954-9.
2007: Simon Florian Preuss; Gero Quante; Robert Semrau; Rolf-Peter Mueller; Jens Peter Klussmann; Orlando Guntinas-Lichius
An analysis of surgical complications, morbidity, and cost calculation in patients undergoing multimodal treatment for operable oropharyngeal carcinoma.
The Laryngoscope 2007;117(1):101-5.
2006: Frederike C Ling; Nadine Leimbach; Stephan E Baldus; Sandra Buechel; Susanne Neiss; Jan Brabender; Uta Drebber; Hans P Dienes; Rolf-Peter Mueller; Arnulf H Hoelscher; Paul M Schneider
HIF-1alpha mRNA is not associated with histopathological regression following neoadjuvant chemoradiation in esophageal cancer.
Anticancer research 2006;26(6B):4505-9.
2006: Orlando Guntinas-Lichius; J Peter Klussmann; Stephen Dinh; Mai Dinh; Matthias Schmidt; Robert Semrau; Rolf-Peter Mueller
Diagnostic work-up and outcome of cervical metastases from an unknown primary.
Acta oto-laryngologica 2006;126(5):536-44.
2006: Robert Semrau; Rolf-Peter Mueller; Hartmut Stuetzer; Susanne Staar; Ursula Schroeder; Orlando Guntinas-Lichius; Martin Kocher; Hans Theodor Eich; Andreas Dietz; Michael Flentje; Volker Rudat; Peter Volling; Michael Schroeder; Hans Edmund Eckel
Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer.
International journal of radiation oncology, biology, physics 2006;64(5):1308-16.
2006: Karsten Krüger; Mark Bendel; Markus Zaehringer; David Strohe; Christopher Bangard; Carsten Weise; Rolf-Peter Mueller; Klaus Lackner
Endovascular gamma irradiation for the prevention restenosis after angioplasty of femoropopliteal de novo stenoses.
European radiology 2006;16(2):399-406.
2005: Huan Xi; Stephan E Baldus; Ute Warnecke-Eberz; Jan Brabender; Susanne Neiss; Ralf Metzger; Frederike C Ling; Hans P Dienes; Elfriede Bollschweiler; Stefan P Moenig; Rolf-Peter Mueller; Arnulf H Hoelscher; Paul M Schneider
High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8341-7.
2005: Paul M Schneider; Stephan E Baldus; Ralf Metzger; Martin Kocher; Rudolf Bongartz; Elfriede Bollschweiler; Hartmut Schaefer; Juergen Thiele; Hans P Dienes; Rolf-Peter Mueller; Arnulf H Hoelscher
Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
Annals of surgery 2005;242(5):684-92.
2005: Ute Warnecke-Eberz; Shuichi Hokita; Huan Xi; Hiroshi Higashi; Stephan E Baldus; Ralf Metzger; Jan Brabender; Elfriede Bollschweiler; Rolf-Peter Mueller; Hans P Dienes; Arnulf H Hoelscher; Paul M Schneider
Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
Oncology reports 2005;13(6):1241-6.
2004: Futoshi Miyazono; Ralf Metzger; Ute Warnecke-Eberz; Stephan E Baldus; Jan Brabender; Elfriede Bollschweiler; Walter Doerfler; Rolf-Peter Mueller; Hans P Dienes; Takashi Aikou; Arnulf H Hoelscher; Paul M Schneider
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer.
British journal of cancer 2004;91(4):666-72.
2004: Ute Warnecke-Eberz; Ralf Metzger; Futoshi Miyazono; Stephan E Baldus; Susanne Neiss; Jan Brabender; Hartmut Schaefer; Walter Doerfler; Elfriede Bollschweiler; Hans P Dienes; Rolf-Peter Mueller; Peter V Danenberg; Arnulf H Hoelscher; Paul M Schneider
High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3794-9.
2004: Karsten Krüger; Markus Zaehringer; Mark Bendel; Hartmut Stuetzer; David Strohe; Monika Nolte; Daniele Wittig; Rolf-Peter Mueller; Klaus Lackner
De novo femoropopliteal stenoses: endovascular gamma irradiation following angioplasty--angiographic and clinical follow-up in a prospective randomized controlled trial.
Radiology 2004;231(2):546-54.
2002: Karsten Krüger; Peter Landwehr; Mark Bendel; Monika Nolte; Hartmut Stuetzer; Rudolf Bongartz; Markus Zaehringer; Guido Winnekendonk; Axel Gossmann; Rolf-Peter Mueller; Klaus Lackner
Endovascular gamma irradiation of femoropopliteal de novo stenoses immediately after PTA: interim results of prospective randomized controlled trial.
Radiology 2002;224(2):519-28.
2001: Susanne Staar; Volker Rudat; Hartmut Stuetzer; Andreas Dietz; Peter Volling; M Schroeder; Michael Flentje; Hans Edmund Eckel; Rolf-Peter Mueller
Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.
International journal of radiation oncology, biology, physics 2001;50(5):1161-71.
1999: Susanne Staar; Ralf Krott; Rolf-Peter Mueller; Karl Ulrich Bartz-Schmidt; K Heimann
External beam radiotherapy for subretinal neovascularization in age-related macular degeneration: is this treatment efficient?
International journal of radiation oncology, biology, physics 1999;45(2):467-73.
1998: Martin Kocher; Jürgen Voges; Susanne Staar; Harald Treuer; Volker Sturm; Rolf-Peter Mueller
Linear accelerator radiosurgery for recurrent malignant tumors of the skull base.
American journal of clinical oncology 1998;21(1):18-22.